Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2005

01-09-2005 | Concise article

Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections

Authors: F. Gutiérrez, M. Masiá, J. Ramos, M. Elía, E. Mellado, M. Cuenca-Estrella

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2005

Login to get access

Abstract

The first case of pulmonary fungus ball caused by Paecilomyces species is reported. The diagnosis was established by isolation of the fungus in culture from specimens obtained by percutaneous transthoracic needle aspiration in an immunocompetent individual. The isolate was atypical, as it failed to produce fruiting structures on routine mycological media. Identification was achieved by sequencing polymorphisms of the internal transcriber spacer regions of the ribosomal DNA. The antifungal susceptibility profile was also determined. This report underscores the increasing importance of Paecilomyces species in human infections. Paecilomyces should be included among the etiological agents of pulmonary mycetoma.
Literature
1.
Sigler L, Kennedy MJ (1999) Aspergillus, Fusarium, and other opportunistic moniliaecious fungi. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology, 7th edn. Washington DC, pp 1231–1235
2.
Castro LGM, Salebian A, Sotto MN (1990) Hyalohyphomycosis by Paecilomyces lilacinus in a renal transplant patient and a review of human Paecilomyces species infections. J Med Vet Mycol 28:15–26PubMedCrossRef
3.
Williamson PR, Kwong-Chung KL, Gallin JI (1992) Successful treatment of Paecilomyces variotii infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis 14:1023–1026PubMed
4.
Gutiérrez Rodero F, Moragon M, Ortiz de la Tabla V, Mayol MJ, Martin C (1999) Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review. Eur J Clin Microbiol Infect Dis 18:814–818CrossRefPubMed
5.
Carey J, D'Amico R, Sutton DA, Rinaldi MG (2003) Paecilomyces lilacinus vaginitis in an immunocompetent patient. Emerg Infect Dis 9:1155–1158PubMed
6.
Gucalp R, Carlisle P, Gialanella P, Mitsudo S, McKitrick J, Dutcher J (1996) Paecilomyces sinusitis in an immunocompetent adult patient: case report and review. Clin Infect Dis 23:391–393PubMed
7.
Scott IU, Flynn HW Jr, Miller D, Speights JW, Snip RC, Brod RD (2001) Exogenous endophthalmitis caused by amphotericin B-resistant Paecilomyces lilacinus: treatment options and visual outcomes. Arch Ophthalmol 119:916–919PubMed
8.
Wilhelmus KR, Robinson NM, Font RA, Hamill MB, Jones DB (1998) Fungal keratitis in contact lens wearers. Am J Ophthalmol 106:708–714
9.
Martin CA, Roberts S, Greenberg RN (2002) Voriconazole treatment of disseminated Paecilomyces infection in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 35:e78–e81CrossRefPubMed
10.
Chan-Tack KM, Thio CL, Miller NS, Karp CL, Ho C, Merz WG (1999) Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. Med Mycol 37:57–60CrossRefPubMed
11.
Dharmasena FM, Davies GS, Catovsky D (1985) Paecilomyces variotii pneumonia complicating hairy cell leukaemia. Br Med J 290:967–968CrossRef
12.
Chan TH, Koehler A, Li PK (1996) Paecilomyces variotii peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 27:138–142PubMed
13.
Cohen-Abbo A, Edwards KM (1995) Multifocal osteomyelitis caused by Paecilomyces variotii in a patient with chronic granulomatous disease. Infection 23:55–57CrossRefPubMed
14.
Kalish SB, Goldschmidt R, Li C, Knop R, Cook FV, Wilner G, Victor TA (1982) Infective endocarditis caused by Paecilomyces variotii. Am J Clin Pathol 78:249–252PubMed
15.
Fenech FF, Mallia CP (1972) Pleural effusion caused by Penicillium lilacinum. Br J Dis Chest 66:284–290CrossRefPubMed
16.
Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, Rodriguez-Tudela JL (2001) Identification of two different 14-a sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol 39:2431–2438CrossRefPubMed
17.
National Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. NCCLS, Wayne, PA
18.
Rodriguez-Tudela JL, Chryssanthou E, Petrikkou E, Mosquera J, Dennning DW, Cuenca-Estrella M (2003) Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. J Clin Microbiol 41:5236–5237CrossRefPubMed
19.
Denning DW, Radford SA, Oakley KL, Hall L, Johnson EM, Warnock DW (1997) Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 40:401–414CrossRefPubMed
20.
Byrd RP Jr, Roy TM, Fields CL, Lynch JA (1992) Paecilomyces variotii pneumonia in a patient with diabetes mellitus. J Diabetes its Complicat 6:150–153CrossRef
21.
Sillevis JH, Leusen JH, Stas HG, Teeuw AH, Weeningb RS (1997) Chronic bullous disease of childhood and a Paecilomyces lung infection in chronic granulomatous disease. Arch Dis Child 77:150–152PubMed
22.
Ono N, Sato K, Yokomise H, Tamura K (1999) Lung abscess caused by Paecilomyces lilacinus. Respiration 66:85–87CrossRefPubMed
23.
Das A, MacLaughlin EF, Ross LA, Monforte HL, Horn MV, Lam GL, Mason WH (2000) Paecilomyces variotii in a pediatric patient with lung transplantation. Pediatr Transplant 4:328–432CrossRefPubMed
24.
Ortoneda M, Capilla J, Pastor FJ, Pujol I, Yustes C, Serena C, Guarro J (2004) In vitro interactions of approved and novel drugs against Paecilomyces spp. Antimicrob Agents Chemother 48:2727–2729CrossRefPubMed
25.
Perfect JR, Schell WA (1996) The new fungal opportunists are coming. Clin Infect Dis 22(Suppl 2):112–118
26.
Espinel-Ingroff A (2001) In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 39:954–958CrossRefPubMed
27.
Hilmarsdottir I, Thorsteinsson SB, Asmundsson P, Bodvarsson M, Arnadottir M (2000) Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole. Scand J Infect Dis 32:331–332CrossRefPubMed
28.
Garbino J, Ondrusova A, Baglivo E, Lew D, Bouchuiguir-Wafa K, Rohner P (2002) Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole. Scand J Infect Dis 34:701–703CrossRefPubMed
29.
Soubani AO, Chandrasekar PH (2002) The clinical spectrum of pulmonary aspergillosis. Chest 121:1988–1999CrossRefPubMed
Metadata
Title
Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections
Authors
F. Gutiérrez
M. Masiá
J. Ramos
M. Elía
E. Mellado
M. Cuenca-Estrella
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2005
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-005-0013-y

Other articles of this Issue 9/2005

European Journal of Clinical Microbiology & Infectious Diseases 9/2005 Go to the issue

Concise Article

Linezolid treatment of ventriculoperitoneal shunt infection without implant removal

Brief Report

Clearance of GB virus C during highly active antiretroviral therapy and course of HIV disease progression in HIV-infected patients with hemophilia

Concise Article

Minimal inhibitory concentrations of linezolid against clinical isolates of coryneform bacteria

Concise Article

Three cases of cardiac complications associated with Campylobacter jejuni infection and review of the literature

Concise Article

Cytomegalovirus cholangitis presenting with recurrent hemobilia

Concise Article

Evaluation of a commercial enzyme immunoassay for detection of norovirus in outbreak specimens
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits